Live from the NIH registry
Studies recruiting near Oxnard right now
Top 25 of 120 recruiting studies, sorted by proximity — each links to its official registry page
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Vitiligo, Non-Segmental Vitiligo (NSV)
Phase 2
Interventional 66 participants sought
Cura Clinical Research - Oxnard — Oxnard, California (0.3 mi)
· Sponsor: Eli Lilly and Company
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Lower Extremity Acute Limb Ischemia, LE ALI
N/A
Observational 300 participants sought
Community Memorial Hospital — Ventura, California (8.5 mi)
· Sponsor: Penumbra Inc.
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
Coronary Artery Disease, High Risk Percutaneous Coronary Intervention
N/A
Interventional 358 participants sought
Los Robles Regional Medical Center — Thousand Oaks, California (19.7 mi)
· Sponsor: Supira Medical
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Acute Ischemic Stroke, Cerebral Stroke
Phase 3
Interventional 514 participants sought
St. John's Regional Medical Center — Oxnard, California (0.3 mi)
· Sponsor: Pharmazz, Inc.
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Care Access Research — Thousand Oaks, California (19.7 mi)
· Sponsor: Boehringer Ingelheim
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Atrial Fibrillation (AF)
Phase 2
Interventional 1,200 participants sought
Cardiology Associates Medical Group — Ventura, California (8.5 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Om Research, LLC 2 — Oxnard, California (0.3 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Crohn Disease
Phase 2
Interventional 60 participants sought
Om Research LLC — Oxnard, California (0.3 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 1,800 participants sought
89bio Clinical Study Site — Camarillo, California (8.3 mi)
· Sponsor: Hoffmann-La Roche
ATLAS (AltaValve) Pivotal Trial
Mitral Regurgitation, Mitral Insufficiency
N/A
Interventional 450 participants sought
Los Robles Hospital & Medical Center — Thousand Oaks, California (19.7 mi)
· Sponsor: 4C Medical Technologies, Inc.
Resmetirom in Patients With MASH and HFpEF
MASH - Metabolic Dysfunction-Associated Steatohepatitis, Heart Failure With Preserved Ejection Fraction (HFPEF)
Phase 1
Interventional 90 participants sought
FOMAT - Clinicas Mi Salud — Oxnard, California (0.3 mi)
· Sponsor: Madrigal Pharmaceuticals, Inc.
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Urothelial Carcinoma
Phase 2
Interventional 372 participants sought
UCLA Hematology/Oncology - Ventura — Ventura, California (8.5 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Ventura County Hematology Oncology Specialists — Oxnard, California (0.3 mi)
· Sponsor: Paradigm Health
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
Primary Sjögren's Syndrome
Phase 2
Interventional 180 participants sought
Site Number - 1029 — Thousand Oaks, California (19.7 mi)
· Sponsor: Immunovant Sciences GmbH
Patient Retrospective Outcomes (PRO)
Chronic Pain
N/A
Observational 15,000 participants sought
Pacific Pain Management, Inc. — Ventura, California (8.5 mi)
· Sponsor: Boston Scientific Corporation
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
HER2-negative Breast Cancer Patients With Brain Metastases
Phase 2
Interventional 120 participants sought
FOMAT Medical Research (Network) — Oxnard, California (0.3 mi)
· Sponsor: Biostar Pharma, Inc.
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Radiographic Axial Spondyloarthritis
Phase 2
Interventional 315 participants sought
Cohen Medical Centers ( Site 0034) — Thousand Oaks, California (19.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 36 — Oxnard, California (0.3 mi)
· Sponsor: BioStem Technologies
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Immunoglobulin A Nephropathy (IgAN)
Phase 3
Interventional 454 participants sought
FOMAT Medical Research - FOMAT - PPDS — Oxnard, California (0.3 mi)
· Sponsor: Biogen
Phase 2/3 Efficacy and Safety of PP405 in Adult Males
Androgenetic Alopecia
Phase 2, Phase 3
Interventional 600 participants sought
Clinical Trials Research Institute — Thousand Oaks, California (19.7 mi)
· Sponsor: Pelage Pharmaceuticals, Inc.
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Ventura, California (8.5 mi)
· Sponsor: Medtronic
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Phase 3
Interventional 980 participants sought
Om Research, LLC - Oxnard - Site Number: 8400150 — Oxnard, California (0.3 mi)
· Sponsor: Sanofi
Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers
Diabetic Foot, Ulcer Foot
N/A
Interventional 100 participants sought
Performance Foot and Ankle Specialists — Thousand Oaks, California (19.7 mi)
· Sponsor: Axolotl Biologix
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
California Retina Consultants-Oxnard-70187 — Oxnard, California (0.3 mi)
· Sponsor: Boehringer Ingelheim
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
N/A
Observational 8,000 participants sought
Spanish Hills Surgery Center — Camarillo, California (8.3 mi)
· Sponsor: Stryker Instruments